Insider Transactions Reported by 22 Insiders of BALCHEM CORP

Symbol
BCPC on Nasdaq
Location
Montvale, NJ

Insiders trading volume in the past year

BALCHEM CORP executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Theodore L. Harris Chairman, President & CEO, Director $16,522,212 11 Feb 2026
Perry W. Premdas Director $6,711,291 08 Feb 2023
Carl Martin Bengtsson EVP & Chief Financial Officer $5,111,894 11 Feb 2026
JOHN Y. TELEVANTOS Director $3,825,888 13 Feb 2023
Michael Brent Tignor SVP & Chief HR Officer $2,116,449 11 Feb 2026
James C. Hyde Sr. Vice President $2,093,989 15 Feb 2022
Jonathan Harrison Griffin SVP & GM, Animal Nutrition $1,851,068 11 Feb 2024
Job Leonard van Gunsteren SVP and GM, Specialty Products $1,801,346 -$919,723 -34% 11 Feb 2026
Martin Luther Reid SVP Chief Supply Chain Officer $1,701,888 -$185,328 -9.8% 11 Feb 2026
Frederic Boned SVP/GM, Human Nutri. & Health $1,644,405 11 Feb 2026
Hatsuki Miyata EVP, CLO, & Secretary $1,610,880 11 Feb 2026
David B. Fischer Director $1,231,466 -$1,231,748 -50% 11 Feb 2026
William A. Backus VP & Chief Accounting Officer $1,223,632 11 Feb 2026
Matthew David Wineinger Director $1,165,146 11 Feb 2026
Mark A. Stach General Counsel $1,021,404 15 Feb 2022
Daniel E. Knutson Director $983,571 11 Feb 2026
Michael Robert Sestrick SVP & Chief Technology Officer $915,216 12 Feb 2025
Kathleen B. Fish Director $417,475 11 Feb 2026
Joyce J. Lee Director $398,162 08 Feb 2024
Olivier Rigaud Director $247,973 11 Feb 2026
MONICA VICENTE Director $247,973 11 Feb 2026
George Graham SVP and Chief R&D Officer 11 Feb 2026

Recent Insider Transactions by Companies or Individuals for BALCHEM CORP

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.